Assessment of myocardial viability by dobutamine stress echocardiography

Current Opinion in Cardiology

Volumn 11, Issue 6, 1996, Pages 621-626

  Cornel, Jan H ^a   Bax, Jeroen J ^a   Fioretti, Paolo M ^a  

^a Location Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029822629     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199611000-00011     Document Type: Short Survey

References (29)

1. Lindner JR, Kaul S: Assessment of myocardial viability with two-dimensional echocardiography and magnetic resonance imaging. J Nucl Cardiol 1996, 3:167-182.
2. Cheirif J, Murgo JP: Assessment of myocardial viability by dobutamine echocardiography. Coran Artery Dis 1995, 6:600-605.
3. Cornel JH, Balk AHMM, Amese M, Maat APWM, Elhendy A, Boersma E, Salustri A, Roelandt JRTC, Fioretti PM: Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996, 9:27-32. Documents the safety of dobutamine-atropine stress in patients with moderate to severe left ventricular dysfunction.
4. Faletra F, Crivellaro W, Pirelli S, Parodi O, De Chiara F, Cipriani M, Corno R, Pezzano A: Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior wall myocardial infarction. Am J Cardiol 1995, 76:1002-1006. This study demonstrates that reduced myocardial wall thickness is a sign of scar tissue formation in patients with chronic coronary artery disease.
5. 18F] fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995, 91:1006-1015.
6. 201TI stress-reinjection SPECT for the detection of functional improvement after surgical revascularization.
7. Meluzin J, Cigarroa CG, Brickner ME, Cemy J, Spinarova L, Frelich M, Stetka F, Groch L, Grayburn PA: Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995; 76:877-880. Important study relating the extent of contractile reserve to improvement in LVEF after revascularization.
8. Hoffmann R, Lethen H, Warwick T, Arnese M, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flachskampf FA, Hanrath P: Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996, 27:330-336. A multicenter European study documenting the intercenter agreement in the reading of DSE for detection of coronary artery disease.
9. Borges AC, Pingitore A, Cordovil A, Sicari R, Baumann G, Picano E: Heterogeneity of left ventricular regional wall thickening following dobutamine infusion in normal human subjects: a quantitative two-dimensional echocardiographic study. Eut Heart J 1995, 16:1726-1730. The research group from Pisa describes the heterogeneity of mechanical function of normal myocardium at rest and in response to dobutamine.
10. Carstensen S, Ali SM, Stensgaard-Hansen FV, Toft J, Haunso S, Kelbaek H, Saunamäki K: Dobutamine-atropine stress echocardiography in asymptomatic healthy individuals: the relativity of stress-induced hyperkinesla. Circulation 1995, 92:3453-3463. In this study in normal human subjects, measures of wall thickening increased from baseline in response to low-dose dobutamine infusion but decreased subsequently in response to peak infusion. This study questions the criteria currently used for interpretation of DSE.
11. Sklenar J, Ismail S, Villanueva FS, Goodman C, Glasheen WP, Kaul S: Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: an experimental evaluation. Circulation 1994, 90:1502-1512.
12. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA: Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995, 91:663-670.
13. Chen C, Li L, Chen LL, Prada JV, Chen MH, Fallon JT, Weyman AE, Waters D, Gillam L: Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995, 92:756-766. Experimental study showing that a biphasic response to incremental doses of dobutamine is characteristic of ischemic or short-term hibernating myocardium.
14. Senior R, Lahiri A: Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995, 26:26-32. Comparative study demonstrating enhanced detection of ischemia when a biphasic response is added as a sign of myocardial ischemia.
15. 201TI SPECT.
16. Weissman NJ, Nidorf SM, Guerrero JL, Weyman AE, Picard MH: Optimal stage duration in dobutamine stress echocardiography. J Am Coll Cardiol 1995, 25:605-609.
17. Picano E, Ostojic M, Varga A, Sicari R, Djordjevic-Dikic A, Nedeljkovic I, Torres M: Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 1996, 27:1422-1428. This study proposes an alternative protocol for detecting myocardial viability and describes enhanced sensitivity in predicting functional recovery in comparison with low-dose DSE.
18. Baer FM, Voth E, Deutsch HJ, Schneider CA, Schicha H, Sechtem U: Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994, 24:343-353.
19. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT: Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995, 91:990-998.
20. 201TI reinjection imaging for identifying hibernating myocardium capable of improving after revascularization.
21. Vanoverschelde J-LJ, Gerber BL, D'Hondt A-M, De Kock M, Dion R, Wijns W, Melin JA: Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995, 92(suppl 2):37-44. This study demonstrates that contractile reserve as well as baseline end-diastolic volume are independent predictors of postoperative improvement in global left ventricular function.
22. deFilippi CR, Willett DWL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA: Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995, 92:2863-2868. This study confirms previous findings that contractile reserve is a better predictor than myocardial perfusion of functional improvement after revascularization.
23. Iliceto S, Galiuto L, Marchese A, Cavallari D, Colonna P, Biasco G, Rizzon P: Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996, 77:441-445.
24. Chan RKM, Lee KJ, Calafiore P, Berlangieri SU, McKay WJ, Tonkin AM: Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic Ischemic left ventricular dysfunction. J Am Coll Cardiol 1996, 27:1601-1607.
25. Senior R, Glenville B, Basu S, Sridhara BS, Anagnostou E, Stanbridge R, Edmondson SJ, Handler CE, Raftery EB, Lahiri A: Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995, 74:358-364.
26. Voci P, Bilotta F, Caretta Q, Mercanti C, Marino B: Low-dose dobutamine echocardiography predicts the early response of dysfunctioning myocardial segments to coronary artery bypass grafting. Am Heart J 1995, 129:521-526.
27. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995, 91:2556-2565. This study demonstrates that contractile reserve during dobutamine echocardiography is highly predictive of improvement of hypoperfused myocardium after revascularization.
28. Kao HL, Wu CC, Ho YL, Chen WJ, Lee CM, Chen MF, Liau CS, Lee YT: Dobutamine stress echocardiography predicts early wall motion improvement after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1995, 76:652-656.
29. Williams MJ, Odabashian J, Laurer MS, Thomas JD, Warwick TH: Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996, 27:132-139. Important study from the Cleveland Clinic Foundation relating the results of DSE in terms of presence or absence of viability or ischemia to prognosis in medically treated patients.